A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

Automated summary

Pneumococcal pneumonia remains a global public health issue. Malaysia has added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme, but there is a lack of representative population-based pneumococcal surveillance in Malaysia, hindering the assessment of vaccine effectiveness and future vaccine policy.